RNA Foundation Models to Improve Pharma R&D Productivity
As RNA biology and RNA therapeutics emerge in the mainstream of pharma, RNA foundation models offer massive potential for revolutionizing R&D.
Brendan Frey
Brendan Frey is a renowned entrepreneur, engineer, and scientist, serving as the Chief Innovation Officer and Founder of Deep Genomics. He co-founded the Vector Institute for Artificial Intelligence and has made significant contributions in deep learning, genomic medicine, and information technology. Brendan has co-authored over 200 papers, many of which appeared in prestigious scientific journals like Nature, Science, and Cell. His pioneering work on the 'wake-sleep algorithm' with Geoffrey Hinton contributed to the establishment of deep learning. Brendan's expertise in AI led to the founding of Deep Genomics, where he developed the first AI system for predicting pathogenic mutations and therapeutic targets. He also holds positions at the University of Toronto and is a Fellow of several esteemed scientific associations. Brendan's advisory roles at Microsoft Research and his extensive academic background further demonstrate his influential contributions to the field of AI and biomedical research.